Hepatorenal syndrome
✍ Scribed by Nathalie Ganne-Carrié; Antoine Hadengue; Philippe Mathurin; François Durand; Serge Erlinger; Jean-Pierre Benhamou
- Publisher
- Springer US
- Year
- 1996
- Tongue
- English
- Weight
- 254 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0163-2116
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background & Aims: Hepatic myelopathy is a rare complication of chronic liver disease, causing progressive spastic paraparesis. Today, no therapy of this disorder has been established. Commonly used therapeutic strategies for hepatic encephalopathy aiming at the reduction of plasma ammonia levels su
A urinary sodium concentration [U(Na)] of less than 10 mmoles per liter is considered important in differentiating hepatorenal syndrome from other causes of progressive renal impairment in patients with liver disease. However, occasionally, patients with hepatorenal syndrome have been recognized in